Gatifloxacin Hydrochloride
CAS No. | 160738-57-8 | Cat. No. | BCP10389 |
Name | Gatifloxacin Hydrochloride | ||
Synonyms | Gatifloxacin HCl;AM 1155 hydrochloride; BMS 206584-01 hydrochloride; PD 135432 hydrochloride; | ||
Formula | C22H28FN3O7 | M. Wt | 465.47 |
Description | Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family that inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Gatifloxacin is a fluoroquinolone antibiotic, with potent activity against Gram-negative and Gram-positive bacteria. Bristol-Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin for the treatment of respiratory tract infections. Allergan produces it in eye-drop formulation under the names Zymar and Zymaxid. In many countries, gatifloxacin is also available as tablets and in various aqueous solutions for intravenous therapy. | ||
Pathways | Microbiology/Virology | ||
Targets | Antibiotic |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.